Cystine capacity is an assay for assessing urinary cystine saturation and risk of a stone episode in patients with cystinuria. Lowering the threshold for this test improves its sensitivity, potentially enabling relaxation of follow-up regimens for patients at lowest risk of stone episodes and dose modification of medications for those at highest risk.
References
Friedlander, J. I. et al. Do urinary cystine parameters predict clinical stone activity? J. Urol. http://dx.doi.org/10.1016/j.juro.2017.09.034 (2017).
Coe, F. L., Clark, C., Parks, J. H. & Asplin, J. R. Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugs. J. Urol. 166, 688–693 (2001).
Dolin, D. et al. Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria. J. Endourol. 19, 429–432 (2005).
Wong, K. et al. Can the presence of crystalluria predict stone formation in patients with cystinuria? J. Endourol. 30, 609–614 (2016).
Pardy, C. et al. Urinary lysine is a better predictor of cystine stone formation than urinary cystine. Eur. Urol. Suppl. 10, 227 (2011).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Bultitude, M., Thomas, K. Predicting stone episodes using cystine capacity. Nat Rev Urol 15, 8–9 (2018). https://doi.org/10.1038/nrurol.2017.189
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2017.189
- Springer Nature Limited